Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-01-03 @ 7:23 PM
Study NCT ID:
NCT00827359
Status:
COMPLETED
Last Update Posted:
2021-02-24
First Post:
2009-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
08-313
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None